Pathological features of Alzheimer’s disease (AD) include accumulation and deposition of β-amyloid (Aβ) in the brain, activation of astrocytes and microglia, and disruption of cholinergic neurotransmission. In our experiments on rats, a model of AD was created by intracerebroventricular (i.c.v.) injections of Aβ25–35 amyloid. In another animal group, this was combined with intramuscular (i.m.) injections of small doses of Macrovipera lebetina (ML) snake venom (50 μl of 5% solution of an LD50 dose per animal seven times with one-day-long intervals). In the AD model, the most vulnerable neurons were found in the hippocampal fields CA1 and CA3. The phosphatase activity in the hippocampus of Aβ-injected rats sharply dropped. Systemic administration of small doses of ML venom induced positive changes in the structural characteristics of hippocampal neurons, increased the density of neurons in the above fields, normalized metabolism, and intensified Ca2+-dependent phosphorylation. Under the action of ML venom, the proportion of responses of hippocampal pyramidal neurons after high-frequency tetanic stimulation of the ipsilateral entorhinal cortex in the form of tetanic depression–posttetanic potentiation increased, and an overall increase in the firing rate of hippocampal neurons was observed. The intensity of free radical processes in some tissues of Aβ-affected animals became much lower under the action of ML venom. Thus, small doses of this venom manifest clear neuroprotective effects in the rat AD model.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
F. Asadi, A. H. Jamshidi, F. Khodagholi, et al., “Reversal effects of crocin on amyloid β-induced memory deficit: Modification of autophagy or apoptosis markers,” Pharmacol. Biochem. Behav., 15, 30083-30086 (2015).
J. H. Morrison and P. R. Hof, “Life and death of neurons in the aging cerebral cortex,” Int. Rev. Neurobiol., 81, 41-57 (2007).
J. Shen and J. Wu, “Nicotinic cholinergic mechanisms in Alzheimer’s disease,” Int. Rev. Neurobiol., 124, 275-292 (2015).
J. M. Craft, D. M. Watterson, and L. J. Van Eldik, “Human amyloid β-induced neuroinflammation is an early event in neurodegeneration,” Glia, 53, 484-490 (2006).
E. Detrait, T. Maurice, E. Hanon, et al., “Lack of synaptic vesicle protein SV2B protects against amyloid-β25–35-induced oxidative stress, cholinergic deficit and cognitive impairment in mice,” Behav. Brain Res., 271, 277-285 (2014).
M. Pallas and A. Camins, “Molecular and biochemical features in Alzheimer’s disease,” Current Pharm. Des., 12, 4389-408 (2006).
M. Nagashima, S. Yasuhara, and J. A. Martyn, “Trainof-four and tetanic fade are not always a prejunctional phenomenon as evaluated by toxins having highly specific pre- and postjunctional actions,” Anesth. Analg., 116, 994-1000 (2013).
P. Treppmann, I. Brunk, T. Afube, et al., “Neurotoxic phospholipases directly affect synaptic vesicle function,” J. Neurochem., 117, 757-764 (2011).
R. Chen and S. E. Robinson, “The effect of cobrotoxin on cholinergic neurons in the mouse,” Life Sci., 51, 1013-1019 (1992).
N. A. Ghazaryan, L. A. Ghulikyan, and N. M. Ayvazyan, “Morphological changes of proteolipid giant unilamellar vesicles affected by Macrovipera lebetina obtusa venom visualized with fluorescence microscope,” J. Membrane Biol., 246, 627-632 (2013).
N. Vardjan, M. Mattiazzi, and E. Rowan, “Neurotoxic phospholipase A2 toxicity model: An insight from mammalian cells,” Commun. Integr. Biol., 6, e23600 (2013).
N. A. Ghazaryan, L. Ghulikyan, A. Kishmiryan, et al., “Phospholipases A2 from Viperidae snakes: Differences in membranotropic activity between enzymatically active toxin and its inactive isoforms,” BBA-Biomembranes, 1848, 463-468 (2015).
L. Sanz, N. Ayvazyan, and J. J. Calvete, “Snake venomics of the Armenian mountain vipers Macrovipera lebetina obtusa and Vipera raddei,” J. Proteomics, 71, 198-209 (2008).
H. A. Bimonte-Nelson, A. C. Granholm, M. E. Nelson, and A. B. Moore, “Patterns of neurotrophin protein levels in male and female Fischer 344 rats from adulthood to senescence: how young is ‘young’ and how old is ‘old’?” Exp. Aging Res., 34, 13-26 (2008).
T. Kurtovic, M. L. Balija, N. M. Ayvazyan, and B. Halassy, “Paraspecificity of Vipera ammodytesspecific antivenom towards Montivipera raddei and Macrovipera lebetina obtusa venoms,” Toxicon, 78, 103-112 (2014).
T. Maurice, B. Lockhar, T. Su, and A. Privat, “Reversion of β25–35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists,” Brain Res., 731, 249-253 (1996).
T. Maurice and A. Privat, “Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate beta25–35-amyloid peptide-induced amnesia in mice through a common mechanism,” Neuroscience, 83, 413-428 (1998).
K. Yenkoyan, K. Safaryan, V. Chavushyan, et al., “Neuroprotective action of proline-rich polypeptide-1 in β-amyloid induced neurodegeneration in rats,” Brain Res. Bull., 86, 262-271 (2011).
A. Chilingaryan, A. M. Chilingaryan, and G. G. Martin, “The three-dimensional detection of microvasculatory bed in the brain of white rat Rattus norvegicus by a Ca2+-ATPase method,” Brain Res., 1070, 131-138 (2006).
G. Paxinos and Ch. Watson, The Rat Brain in Stereotaxic Coordinates, Acad. Press, New York (2005).
L. Slomianka, T. Drenth, N. Cavegn, et al., “The hippocampus of the eastern rock sengi: cytoarchitecture, markers of neuronal function, principal cell numbers, and adult neurogenesis,” Front. Neuroanat., 29, 34 (2013), doi: https://doi.org/10.3389/fnana.2013.00034.
D. M. Mann, “Pyramidal nerve cell loss in Alzheimer’s disease,” Neurodegeneration, 5, 423-427 (1996).
T. C. Wen, J. Tanaka, H. Peng, et al., “Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field,” J. Exp. Med., 188, 635-649 (1998).
H. M. Schipper, D. E. Scarborough, R. M. Lechan, and S. Reichlin, “Gomori-positive astrocytes in primary culture: effects of in vitro age and cysteamine exposure,” Brain Res. Dev. Brain Res., 54, 71-79 (1990).
K. Sugaya, M. Chouinard, R. Greene, et al., “Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment,” J. Neurosci., 16, 3427-3443 (1996).
G. Bergers and S. Song, “The role of pericytes in bloodvessel formation and maintenance,” Neurol. Oncol., 7, 452-464 (2005).
W. Kamphuis, J. Middeldorp, and L. Kooijman, “Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease,” Neurobiol. Aging, 35, 492-510 (2014).
V. V. Banin, “Neoplasm of vessels: cellular and molecular mechanisms of regulation,” Morfologia (S. Petersburg), Materials of VІ Congress of Int. Ass. of Morphologists, Кolos readings, 18 (2002).
P. Bianco, M. Riminucci, S. Gronthos, and P. G. Robey, “Bone marrow stromal stem cells: nature, biology, and potential applications,” Stem Cells, 19,180-192 (2001).
M. Tolnay and F. Clavaguera, “Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies,” Neuropathology, 24, 269-283 (2004).
W. F. Gattaz, L. L. Talib, E. L. Schaeffer, et al., “Low platelet iPLA activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study,” J. Neural. Transm., 121, 193-200 (2014).
L. L. Talib, S. R. Hototian, H. P. Joaquim, et al.,“Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients,” Eur. Arch. Psychiat. Clin. Neurosci., 265, 701-706 (2015).
E. L. Schaeffer, O. V. Forlenza, and W. F. Gattaz, “Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease,” Psychopharmacology, 202, 37-51 (2009).
Y. Shirai and M. Ito, “Specific differential expression of phospholipase A2 subtypes in rat cerebellum,” J. Neurocytol., 33, 297-307(2004).
B. Lu and J. H. Chang, “Regulation of neurogenesis by neurotrophins: implications in hippocampus dependent memory,” Neuron Glia Biol., 1, 377-384 (2005).
D. A. Nation, C. E. Wierenga, L. R. Clark, et al., “Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer’s disease,” J. Alzheimers Dis., 36, 689-698 (2013).
J. H. Birnbaum, J. Bali, L. Rajendran, et al., “Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss,” Cell Death Dis., 18, e1791 (2015), doi: https://doi.org/10.1038/cddis.2015.160.
M. P. Mattson and S. L. Chan, “Neuronal and glial calcium signaling in Alzheimer’s disease,” Cell Calcium, 34, 385-397 (2003).
J. Gocel and J. Larson, “Synaptic NMDA receptormediated currents in anterior piriform cortex are reduced in the adult fragile X mouse,” Neuroscience, 221, 170-181 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghazaryan, N.A., Simonyan, K.V., Danielyan, M.H. et al. Neuroprotective Effects of Macrovipera lebetina Snake Venom in the Model of Alzheimer’s Disease. Neurophysiology 49, 412–423 (2017). https://doi.org/10.1007/s11062-018-9704-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-018-9704-8